BiotechTube
Home/Slam BioTherapeutics/Rick Heinick
RH

Rick Heinick

CEO and Chairman

Slam BioTherapeutics

Therapeutic Areas

OncologyHematology

Slam BioTherapeutics Pipeline

DrugIndicationPhase
SLM124MDS, AML, CTCL, FLPreclinical

Leadership Team at Slam BioTherapeutics

CW
Chan Whiting, PhD
Chief Scientific Officer
DS
Dr. Steven Rosen
SAB Chair and Co-Founder
View full Slam BioTherapeutics profile